Committed to improving the lives of patients with short bowel syndrome and intestinal failure (SBS-IF) If you or someone you care for is living with SBS-IF and want to learn more about the STARS study, please go to www.SBStrial.com. Apraglutide is an investigational agent not approved in any region. SBS-IF: Short Bowel Syndrome with Intestinal Failure STARS™ is a trademark owned or licensed by VectivBio, its subsidiaries, or affiliates. © VectivBio AG, 2022. All Rights Reserved. VB100822_013http://www.SBStrial.com